November 9, 2016
Empowering clinical research laboratories to achieve new levels of productivity SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM) and GenomOncology today announced a distribution agreement to co-market the GO Clinical Workbench™ for molecular interpretation of somatic variants identified using Fluidigm systems. An elegant solution for clinical research laboratories seeking accuracy, flexibility, and scalability, this combined offering [...]
November 9, 2016
Agreement builds on existing collaboration to develop cell-free DNA (cfDNA) Reference Standards to support CareDx’s solid organ transplant injury monitoring tests Ongoing collaboration supports strategy to provide reliable revenue through the inclusion of Horizon’s HDxTM Reference Standards in established assay workflows Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application [...]
Thomas Studhalter nominated for election to the Board of Directors of Datacolor
November 9, 2016
Lucerne, Switzerland Thomas Studhalter nominated for election to the Board of Directors of Datacolor The Board of Directors of Datacolor AG proposes to the Ordinary Annual General Meeting on December 6, 2016 to elect Thomas Studhalter (1969, CH) as an additional member of the Board of Directors. Thomas Studhalter holds a degree in Business Administration [...]
New Inverted Research Microscope ECLIPSE Ti2
November 9, 2016
Nikon Corporation (Kazuo Ushida, President, Tokyo) is pleased to announce the release of the ECLIPSE Ti2 Inverted Research Microscope. The new ECLIPSE Ti2 Research Microscope is the successor to the ECLIPSE Ti, which has been highly successful in the inverted research microscope market. This product will be presented at “Neuroscience 2016 - Society for Neuroscience” [...]
New Objective lens for Biological Microscope CFI Plan Apochromat 10XC Glyc
November 9, 2016
Nikon Corporation (Kazuo Ushida, President, Tokyo) is pleased to announce the release of the new objective lens CFI Plan Apochromat 10XC Glyc. The CFI Plan Apochromat 10XC Glyc is for deep tissue imaging, compatible with a wide variety of tissue clearing techniques* and refractive indices highly demanded by neuroscience research. This product will be presented at [...]
Thermo Fisher Scientific Expands Portfolio of Next-Generation Sequencing Cancer Research Assays
November 9, 2016
New Oncomine products enable immune response analysis of the tumor microenvironment, interrogation of BRCA 1-2 genes, and liquid biopsy research using cell-free DNA from breast and colon cancer samples CARLSBAD, Calif.--Thermo Fisher Scientific today announced four new additions to its portfolio of multi-biomarker targeted assays for cancer research, including the Oncomine Immune Response Research Assay, [...]
SeraCare Life Sciences collaborates with ArcherDX on RNA Fusion Reference Standards
November 9, 2016
Firms will collaborate to support Archer® FusionPlex® NGS-assay customers CHARLOTTE, N.C. and MILFORD, Mass., Nov. 9, 2016 /PRNewswire/ -- SeraCare Life Sciences, a global provider of tools supporting assay development and laboratory QC, and ArcherDX, a leading provider in next-generation sequencing-based assays, are announcing at the AMP Annual Meeting a partnership on the development and [...]
November 9, 2016
Leading molecular pathologists will share performance data demonstrating new faster droplet detection, higher throughput and automated analysis capabilities BILLERICA, Mass. and CHARLOTTE, NC — RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the launch of its RainDrop Plus™Digital PCR System featuring faster droplet detection, higher throughput, and [...]
Scientists develop computer models to predict cancer cell network activity
November 9, 2016
New method most accurate to date CASE WESTERN RESERVE UNIVERSITY A MULTI-INSTITUTION ACADEMIC-INDUSTRIAL PARTNERSHIP OF RESEARCHERS LED BY CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE HAS DEVELOPED A NEW METHOD TO BROADLY ASSESS CELL COMMUNICATION NETWORKS AND IDENTIFY DISEASE-SPECIFIC NETWORK ANOMALIES. THE COMPUTER-BASED METHOD, CALLED INFLO, WAS DEVELOPED IN COLLABORATION WITH RESEARCHERS AT PHILIPS AND [...]
EXACT SCIENCES APPOINTS JEFF ELLIOTT CHIEF FINANCIAL OFFICER
November 8, 2016
Respected diagnostics industry expert will help lead efforts to capitalize on market opportunity for Cologuard MADISON, Wis. -- Exact Sciences Corp. (Nasdaq: EXAS) today announced the appointment of Jeff Elliott as chief financial officer. Mr. Elliott, a former senior research analyst at Robert W. Baird & Co., joined Exact Sciences as vice president, business development and [...]

